Regencell Bioscience Holdings Ltd (NASDAQ:RGC) has a beta value of 2.62 and has seen 1.83 million shares traded in the last trading session. The company, currently valued at $11.72B, closed the last trade at $23.7 per share which meant it lost -$14.31 on the day or -37.65%% during that session. The RGC stock price is -252.74% off its 52-week high price of $83.60 and 99.66% above the 52-week low of $0.08. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.93 million shares traded. The 3-month trading volume is 4.73 million shares.
Regencell Bioscience Holdings Ltd (NASDAQ:RGC) trade information
Sporting -37.65%% in the red in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the RGC stock price touched $23.7 or saw a rise of 71.65%. Year-to-date, Regencell Bioscience Holdings Ltd shares have moved 19184.80%, while the 5-day performance has seen it change 51.34%. Over the past 30 days, the shares of Regencell Bioscience Holdings Ltd (NASDAQ:RGC) have changed 117.01%. Short interest in the company has seen 0.76 million shares shorted with days to cover at 0.16.
Regencell Bioscience Holdings Ltd (RGC) estimates and forecasts
The company’s shares have gained 18392.81% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -60.65% over the past 5 years.
RGC Dividends
Regencell Bioscience Holdings Ltd is expected to release its next earnings report in July this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Regencell Bioscience Holdings Ltd (NASDAQ:RGC)’s Major holders
Insiders own 93.84% of the company shares, while shares held by institutions stand at 0.07% with a share float percentage of 1.10%. Investors are also buoyed by the number of investors in a company, with Regencell Bioscience Holdings Ltd having a total of 7.0 institutions that hold shares in the company. The top two institutional holders are UBS GROUP AG with over 312.0 shares worth more than $1048.0. As of 2024-06-30, UBS GROUP AG held 0.0024% of shares outstanding.
The other major institutional holder is BLACKROCK INC., with the holding of over 238.0 shares as of 2024-06-30. The firm’s total holdings are worth over $800.0 and represent 0.0018% of shares outstanding.
